Valence 로고
인기
로그인
Loading data for TAK — first visit, this takes a few seconds.

관심목록에 추가

Takeda Pharmaceutical Li...

NYSE: TAK · 실시간 가격 · USD
17.38
-0.25 (-1.42%)
종가 기준: Aug 17, 2026, 8:00 PM

Takeda Pharmaceutical Limited (TAK) Stock Price, Analysis & Data

-1.42%

데이터 없음

매수호가n/a
시가총액55.5B
매출 (ttm)4.62T
순이익 (ttm)-163.44B
베타0.10
EPS (ttm)-0.32
P/E (ttm)n/a
선행 P/E32.79
P/B (ttm)1.21
P/S (ttm)0.01
Earnings DateOct 29, 2026
매도호가n/a
거래량2,281,738
평균 거래량 (20일)3,394,983
시가17.40
전일 종가17.63
일중 범위17.29 - 17.44
52주 범위12.99 - 18.90
애널리스트n/a
목표주가n/a
배당$0.62 (3.5%)
배당락일2026년 3월 31일

TAK 소개

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adyno...

[더 보기]
산업 Drug Manufacturers - Specialty & Generic
섹터 Healthcare
IPO 일자 Jan 5, 2010
직원 수 47,029
상장 거래소 NYSE
티커 TAK
웹사이트 https://www.takeda.com
전체 기업 정보

재무 실적

2026년 Takeda Pharmaceutical의 매출은 4.51T로, 전년 4.58T 대비 -1.66% 감소했습니다. 순이익은 -152.39B로, -241.2% 감소했습니다.

재무제표

어닝 서프라이즈

Takeda Pharmaceutical가 Jul 27, 2023에 분기 실적을 발표했습니다:
  • 매출 $1.22T 예상치 하회 $0, 및 10.23% 전년 대비 성장.
  • EPS 28.76 예상치 상회 10.14, 및 -55.06% 전년 대비 감소.

    • 다음 실적 발표

    Takeda Pharmaceutical Limited의 실적 발표 예정일은 Oct 29, 2026, 장 시작 전입니다.
    애널리스트 예상 매출은 ... 업그레이드
    news image

    1일 전 · Zacks

    Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

    news image

    1일 전 · Zacks

    Best Income Stocks to Buy for August 17th

    SBLK, TAK and STBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 17, 2026.

    news image

    2일 전 · Zacks

    New Strong Buy Stocks for August 17th

    TAK, VLO, PFX, SBLK and RELY have been added to the Zacks Rank #1 (Strong Buy) List on August 17, 2026.

    news image

    4일 전 · Benzinga

    Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’

    Venture capitalist Vinod Khosla said artificial intelligence (AI) is rapidly expanding drug discovery, but traditional testing methods have failed to keep pace with the technology’s progress. AI and H...

    news image

    4일 전 · Insider Monkey

    Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?

    On July 30, Keros Therapeutics, Inc. (NASDAQ:KROS) triggered a $20 million development milestone payment from its global partner Takeda Pharmaceutical Company Limited (NYSE:TAK). The payout followed t...

    2 페이지 중 1